USA flag logo/image

An Official Website of the United States Government

A mechanism-based computational tool to optimize pulmonary drug delivery

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2013 / SBIR
Agency Tracking Number:
R43HL120517
Solicitation Year:
2013
Solicitation Topic Code:
NHLBI
Solicitation Number:
PA12-088
Small Business Information
3DT HOLDINGS, LLC
251 N. Illinois Street INDIANAPOLIS, IN 46204-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2013
Title: A mechanism-based computational tool to optimize pulmonary drug delivery
Agency: HHS
Contract: 1R43HL120517-01
Award Amount: $196,237.00
 

Abstract:

DESCRIPTION (provided by applicant): Coronary artery disease (CAD) is a national and worldwide epidemic that places the largest clinical and economic burden on the healthcare system of any disease condition. Patients with stable and acute coronary conditions are often treated with percutaneous coronary intervention (PCI), including stenting. Up to 85% of all coronary stents are under-deployed leading to higher target revascularization rates (TVR), in-stent restenosis, in-stent thrombosis, and therefore, higher mortality. Under-deployment is related to several factors, including inaccurate manufacturer ex vivo versus in vivo pressure/diameter compliance relationships, and thus requires further post-dilatation typically with a stiffer, non-compliant balloon. However, post-dilatation balloons still fail to provide adequate expansion because, similar to the stent deployment balloons, they also rely on ex vivo compliance charts to determine in vivo size. Consequently, a tool is needed to provide accurate balloon sizing information to the clinician in real-time during balloon inflation. A novel conductance balloon (CB) catheter system has been developed that functions as a typical post-dilatation catheter, but with additional functionality for accurate measurement and display of real-time balloon size. The CB catheter utilizes a simple physical law (Ohm's Law) to determine the balloon cross-sectional area (CSA)/diameter through electrical voltage measurements made inside the device during inflation. The sizing results are displayed in-real time on a simple bed-side console display to aid the physician during balloon expansion (i.e., similar to current displays that show pressure during inflation). Preliminary results with the CB catheter system on the bench and in vivo in healthy swine showed excellent accuracy (1.4% diameter error), repeatability (1.1% diameter error), and safety. However, additional work is needed to update the console and catheter and further validate the system in atherosclerotic swine (this PhaseI application) before translation to the clinic (future Phase II application). Therefore, in this Phae I application, we propose the creation of a clinically-ready CB catheter system and its validation in vivo in atherosclerotic swine. Based on the strongphysics foundation of the technology, the excellent preliminary results, and the previously known safety of a related system, the CB catheter system is expected to provide highly accurate and repeatable real-time digital display of balloon size across theentire coronary stent range in any type of diseased vessel condition with virtually no physician training required. After the completion of this Phase I project, we expect a quick and logical translation of the CB catheter system to a Phase II project in man. This project has the ability to impact patients with multiple comorbidities and reach across various NIH Institutes and Centers including the NIDDK, NHLBI, and NINDS. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: A post-dilatation devicethat does not rely on inaccurate pressure/diameter compliance charts is needed to ensure minimal stent area and stent apposition during percutaneous coronary intervention. The purpose of this Phase I proposal is the development and validation (in atherosclerotic swine) of a clinically relevant conductance balloon catheter system that relies on electrical voltage measurements to provide accurate, real- time sizing measurements during stent post-dilatation.

Principal Investigator:

Mark C. Svendsen
317-377-0300
msvendsen@3dtholdings.com

Business Contact:

Jennifer Rhodes
317-377-0300
jrhodes@3dtholdings.com
Small Business Information at Submission:

3DT HOLDINGS, LLC
251 N. Illinois Street INDIANAPOLIS, IN 46204-

EIN/Tax ID: 120867032
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No